Sodium Thiosulfate for Injection Market
Sodium Thiosulfate for Injection Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Sodium Thiosulfate for Injection Market Size and Growth
The Sodium Thiosulfate for Injection market is experiencing notable growth due to its therapeutic applications in treating cyanide poisoning and supporting chemotherapy. Market size is projected to reach approximately $XX million by 2028, driven by increasing healthcare needs, regulatory approvals, and a rising focus on effective antidote solutions.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Pfizer
◍ Hope Pharmaceuticals
◍ Fennec Pharmaceuticals
◍ Nichi-lko Pharmaceutical
◍ Sichuan Huiyu Pharmaceutical
◍ Shanghai Pharmaceuticals Holding
◍ Resources Zizhu Pharmaceutical
◍ Tianjin Kingyork Pharmaccuticals
◍ YaoPharma
The Sodium Thiosulfate for Injection Market features key players like Pfizer, Hope Pharmaceuticals, and Fennec Pharmaceuticals. These companies develop, manufacture, and commercialize sodium thiosulfate products for various therapeutic applications, enhancing market growth through innovation and strategic partnerships. Revenue figures: Pfizer generated $81 billion; Fennec reported $10 million in 2022.
Request Sample Report
Market Segmentation
By Application By Product
◍ 10ml : 0.5g ◍ 20ml : 1g ◍ Cyanide Poisoning
◍ Nitroprusside Poisoning
◍ Soluble Barium Salt Poisoning
◍ Arsenic ◍ Mercury ◍ Lead ◍ Bismuth ◍ Iodine Poisoning ◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
